NDRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.04%

Insider Buying (Last 12 Months): $2,040.50

Insider Selling (Last 12 Months): $0.00

ENDRA Life Sciences Insider Trading History Chart

ENDRA Life Sciences Share Price & Price History

^$3.48

▼ -0.475 (-12.03%)

As of 04/4/2025 04:57 PM ET

Days: 30 | 90 | 365

ENDRA Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/27/2024	Group Ag Ubs	Major Shareholder	Buy	106	$19.25	$2,040.50	4,171
5/18/2023	Michael Milos Thornton	CTO	Buy	8	$2,887.50	$23,100.00	19
5/2/2023	Anthony Digiandomenico	Director	Buy	47	$2,100.00	$98,700.00	58
12/9/2022	Michael Milos Thornton	CTO	Buy	0	$5,950.00	$0.00	10
11/23/2022	Alexander Y Tokman	Director	Buy	5	$297.50	$1,487.50	93
8/22/2022	Michael Milos Thornton	CTO	Buy	0	$23,625.00	$0.00	4
5/26/2022	Michael Milos Thornton	CTO	Buy	0	$18,375.00	$0.00	3
5/18/2022	Michael Milos Thornton	CTO	Buy	14	$385.00	$5,390.00	175
5/17/2022	Francois Roger Michelon	CEO	Buy	2	$332.50	$665.00	55

See Full Table

SEC Filings (Institutional Ownership Changes) for ENDRA Life Sciences (NASDAQ:NDRA)

1.19% of ENDRA Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ENDRA Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/8/2022	Raymond James & Associates	70,854	$49K	0.0%	N/A	0.168%
8/16/2021	State Street Corp	60,300	$0.13M	0.0%	N/A	0.145%
8/16/2021	Goldman Sachs Group Inc.	47,709	$0.10M	0.0%	N/A	0.114%
8/13/2021	Stifel Financial Corp	12,500	$27K	0.0%	N/A	0.030%
8/13/2021	Geode Capital Management LLC	316,482	$0.69M	0.0%	+23.5%	0.759%
8/13/2021	Vanguard Group Inc.	1,709,100	$3.73M	0.0%	+8.1%	4.101%
8/2/2021	Advisor Group Holdings Inc.	44,037	$96K	0.0%	+4,407.4%	0.106%
7/31/2021	GWM Advisors LLC	705,439	$1.54M	0.0%	N/A	1.693%
7/23/2021	Tranquility Partners LLC	12,750	$28K	0.0%	N/A	0.031%
5/21/2021	Citadel Advisors LLC	49,856	$0.13M	0.0%	N/A	0.120%
5/18/2021	Citadel Advisors LLC	49,856	$0.13M	0.0%	N/A	0.120%
5/17/2021	Royal Bank of Canada	15,310	$40K	0.0%	N/A	0.037%
5/14/2021	K.J. Harrison & Partners Inc	65,000	$0.17M	0.0%	-76.6%	0.156%
5/13/2021	Capital Asset Advisory Services LLC	10,065	$26K	0.0%	N/A	0.024%
5/13/2021	Blair William & Co. IL	35,000	$91K	0.0%	N/A	0.084%
5/12/2021	Northern Trust Corp	63,378	$0.17M	0.0%	+112.8%	0.152%
5/12/2021	Geode Capital Management LLC	256,300	$0.67M	0.0%	+300.9%	0.616%
5/12/2021	UBS Group AG	30,513	$79K	0.0%	+399.9%	0.073%
5/4/2021	Ieq Capital LLC	17,111	$44K	0.0%	N/A	0.041%
5/3/2021	Flagship Harbor Advisors LLC	697,026	$1.81M	0.2%	N/A	1.676%
5/3/2021	55I LLC	88,850	$0.23M	0.0%	N/A	0.214%
2/10/2021	Renaissance Technologies LLC	86,400	$65K	0.0%	N/A	0.262%

Data available starting January 2016

See Full Table

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Today's Range

Now: $3.48

$3.52

$3.90

50 Day Range

MA: $4.43

$3.38

$5.40

52 Week Range

Now: $3.48

$3.15

$693.00

Volume

11,466 shs

Average Volume

99,851 shs

Market Capitalization

$1.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19

Who are the company insiders with the largest holdings of ENDRA Life Sciences?: ENDRA Life Sciences' top insider investors include:
Group Ag Ubs (Major Shareholder)
Anthony Digiandomenico (Director)
Michael Milos Thornton (CTO)
Learn More about top insider investors at ENDRA Life Sciences.